» Articles » PMID: 34708776

Role of Optical Coherence Tomography-angiography in Diabetes Mellitus: Utility in Diabetic Retinopathy and a Comparison with Fluorescein Angiography in Vision Threatening Diabetic Retinopathy

Overview
Specialty Ophthalmology
Date 2021 Oct 28
PMID 34708776
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the utility of optical coherence tomography-angiography (OCT-A) in diabetic retinopathy (DR) and comparison versus fluorescein angiography (FA) in vision-threatening diabetic retinopathy (VTDR).

Methods: In this cross-sectional observational study, 60 eyes with no DR (NDR), 60 eyes with non-proliferative diabetic retinopathy (NPDR), and 60 eyes with proliferative diabetic retinopathy (PDR) underwent OCT-A. FA was done in VTDR. OCT-A of the NDR eyes was analyzed by two independent retina specialists. Vessel density (VD) (mm/mm), perfusion density (PD) (%), and foveal avascular zone (FAZ) (mm) area was analyzed among the groups. Montage angiography with vitreoretinal interface (VRI) segmentation was done in PDR. A qualitative comparison was done between OCT-A and FA for features of DR.

Results: OCT-A detected 16.66% of the eyes with microaneurysm and 57.5% of the patients with capillary non-perfusion (CNP) areas in the NDR group. The inter-grader coefficient between the two observers was 0.820 for microaneurysm and 0.880 for CNP. The mean VD in NDR, NPDR, and PDR was 16.865, 13.983, and 11.643 mm/mm. The mean PD in NDR, NPDR, and PDR was 30.595, 26.853, and 23.193%. The VD and PD values were statistically significant (P < 0.001). The mean FAZ area was not statistically significant (NPDR and PDR) (P > 0.05). The VRI showed elevated neovascularization in four eyes. OCT-A delineated microaneurysm and FAZ in 97/97 eyes who underwent FA. The FA failed to delineate FAZ in 2/37 NPDR eyes and 13/60 PDR eyes. The CNP areas (OCT-A) were detectable in all eyes. The FA demonstrated CNP areas in 17/37 and 36/60 eyes in NPDR and PDR, respectively. The FA could show peripheral CNP.

Conclusion: The OCT-A helps in the early diagnosis of DR by providing vascular indices which are consistent with disease progression. OCT-A is non-invasive and ideal for follow-up. FA is a dynamic test with a larger field of view.

Citing Articles

Early Diabetic Retinopathy Evaluation With OCTA: A Study on Vascular Branching and Fragmentation.

Yu Y, Cui S, He Y, Zhang J, Lu N, Yang Y Invest Ophthalmol Vis Sci. 2024; 65(14):21.

PMID: 39656470 PMC: 11636659. DOI: 10.1167/iovs.65.14.21.


QiMing granules for diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.

Zhang Y, Shi M, Peng D, Chen W, Ma Y, Song W Front Pharmacol. 2024; 15:1429071.

PMID: 39239647 PMC: 11374745. DOI: 10.3389/fphar.2024.1429071.


Medical image registration and its application in retinal images: a review.

Nie Q, Zhang X, Hu Y, Gong M, Liu J Vis Comput Ind Biomed Art. 2024; 7(1):21.

PMID: 39167337 PMC: 11339199. DOI: 10.1186/s42492-024-00173-8.


Inter-Rater Reliability of Proliferative Diabetic Retinopathy Assessment on Wide-Field OCT-Angiography and Fluorescein Angiography.

Shah P, Mishra D, Falahat P, Fischer L, Guzman G, Terheyden J Transl Vis Sci Technol. 2023; 12(7):13.

PMID: 37432848 PMC: 10351024. DOI: 10.1167/tvst.12.7.13.


Commentary: Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy.

Rana V, Dogra M, Singh S Indian J Ophthalmol. 2021; 69(11):3224-3225.

PMID: 34708777 PMC: 8725137. DOI: 10.4103/ijo.IJO_2567_21.

References
1.
Hwang T, Jia Y, Gao S, Bailey S, Lauer A, Flaxel C . OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY. Retina. 2015; 35(11):2371-6. PMC: 4623938. DOI: 10.1097/IAE.0000000000000716. View

2.
Cui Y, Zhu Y, Wang J, Lu Y, Zeng R, Katz R . Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy. Br J Ophthalmol. 2020; 105(4):577-581. PMC: 9092310. DOI: 10.1136/bjophthalmol-2020-316245. View

3.
Enders C, Baeuerle F, Lang G, Dreyhaupt J, Lang G, Loidl M . Comparison between Findings in Optical Coherence Tomography Angiography and in Fluorescein Angiography in Patients with Diabetic Retinopathy. Ophthalmologica. 2019; 243(1):21-26. DOI: 10.1159/000499114. View

4.
Kim A, Chu Z, Shahidzadeh A, Wang R, Puliafito C, Kashani A . Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2016; 57(9):OCT362-70. PMC: 4968771. DOI: 10.1167/iovs.15-18904. View

5.
de Carlo T, Chin A, Filho M, Adhi M, Branchini L, Salz D . DETECTION OF MICROVASCULAR CHANGES IN EYES OF PATIENTS WITH DIABETES BUT NOT CLINICAL DIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2015; 35(11):2364-70. DOI: 10.1097/IAE.0000000000000882. View